Stockreport

Halozyme Therapeutics Raises 2026 Guidance After Hypercon, Surf Bio Deals Extend Platform Into 2040s [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF technologies with IP into the mid-2040s and adding hyperconcentration capabilities (up to ~500 mg/mL) to cut injection volumes and enable autoinjector use; Hypercon is e [Read more]